Next Article in Journal
Structural-Dynamics and Binding Analysis of RBD from SARS-CoV-2 Variants of Concern (VOCs) and GRP78 Receptor Revealed Basis for Higher Infectivity
Next Article in Special Issue
Klebsiella pneumoniae Complex Harboring mcr-1, mcr-7, and mcr-8 Isolates from Slaughtered Pigs in Thailand
Previous Article in Journal
Using Oxidative Electrodes to Enrich Novel Members in the Desulfobulbaceae Family from Intertidal Sediments
Previous Article in Special Issue
Dynamic Structure of Yeast Septin by Fast Fluctuation-Enhanced Structured Illumination Microscopy
Review

Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery

1
School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham B4 7ET, UK
2
Sphere Fluidics Limited, The McClintock Building, Suite 7, Granta Park, Great Abington, Cambridge CB21 6GP, UK
*
Author to whom correspondence should be addressed.
Academic Editor: Juan M. Gonzalez
Microorganisms 2021, 9(11), 2330; https://doi.org/10.3390/microorganisms9112330
Received: 28 September 2021 / Revised: 1 November 2021 / Accepted: 3 November 2021 / Published: 11 November 2021
(This article belongs to the Special Issue New Methods in Microbial Research 2.0)
Tuberculosis (TB) remains a global healthcare crisis, with an estimated 5.8 million new cases and 1.5 million deaths in 2020. TB is caused by infection with the major human pathogen Mycobacterium tuberculosis, which is difficult to rapidly diagnose and treat. There is an urgent need for new methods of diagnosis, sufficient in vitro models that capably mimic all physiological conditions of the infection, and high-throughput drug screening platforms. Microfluidic-based techniques provide single-cell analysis which reduces experimental time and the cost of reagents, and have been extremely useful for gaining insight into monitoring microorganisms. This review outlines the field of microfluidics and discusses the use of this novel technique so far in M. tuberculosis diagnostics, research methods, and drug discovery platforms. The practices of microfluidics have promising future applications for diagnosing and treating TB. View Full-Text
Keywords: tuberculosis; Mycobacterium; diagnostics; drug discovery; antibiotics; antimicrobial resistance; microfluidics; single-cell analysis; bioengineered models tuberculosis; Mycobacterium; diagnostics; drug discovery; antibiotics; antimicrobial resistance; microfluidics; single-cell analysis; bioengineered models
Show Figures

Figure 1

MDPI and ACS Style

Molloy, A.; Harrison, J.; McGrath, J.S.; Owen, Z.; Smith, C.; Liu, X.; Li, X.; Cox, J.A.G. Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery. Microorganisms 2021, 9, 2330. https://doi.org/10.3390/microorganisms9112330

AMA Style

Molloy A, Harrison J, McGrath JS, Owen Z, Smith C, Liu X, Li X, Cox JAG. Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery. Microorganisms. 2021; 9(11):2330. https://doi.org/10.3390/microorganisms9112330

Chicago/Turabian Style

Molloy, Antonia, James Harrison, John S. McGrath, Zachary Owen, Clive Smith, Xin Liu, Xin Li, and Jonathan A.G. Cox. 2021. "Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery" Microorganisms 9, no. 11: 2330. https://doi.org/10.3390/microorganisms9112330

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop